Researchers at the Johns Hopkins Kimmel Cancer Center identified a novel cell signaling pathway that potentially could be targeted in therapy for patients with aggressive pancreatic cancers.
Apr 24, 2023
0
32
In a study published in the March 27, 2023, online edition of the New England Journal of Medicine, researchers at the University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health found ...
Mar 27, 2023
0
41
Scientists at VCU Massey Cancer Center have uncovered a previously unrecognized relationship between two sets of proteins that operate in tandem to fend off the growth of pancreatic cancer. The findings could provide pivotal ...
Mar 1, 2023
0
38
New QIMR Berghofer research has found that low-dose aspirin may improve ovarian cancer survival.
Feb 7, 2023
1
108
New research out of VCU Massey Cancer Center points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer. Recently published in Cell Reports, the findings could ...
Nov 30, 2022
0
53
Patients with early-stage breast cancer who had a pathologic complete response (pCR) to neoadjuvant chemotherapy may be able to skip surgery and receive standard radiation treatment with a low chance of disease recurrence, ...
Oct 25, 2022
0
42
Women diagnosed with early-stage breast cancer often can choose to have a lumpectomy, which removes only cancerous tissue and a thin margin of surrounding healthy cells instead of the entire breast. Current cancer guidelines ...
Sep 16, 2022
0
88
A study led by scientists at Roswell Park Comprehensive Cancer Center shows that chemotherapy after surgery for gastric adenocarcinoma is significantly associated with longer survival in patients with chemosensitive disease, ...
Jan 17, 2022
0
44
Women with early-stage breast cancer that has a specific pattern of gene expression are more likely than others to benefit from treatment with a class of common but potentially harmful chemotherapy drugs called anthracyclines, ...
Nov 8, 2019
0
44
Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease—good news from a major study that shows the value of a gene-activity test to gauge each patient's risk.
Sep 28, 2015
0
326
